A rating scale for psychotic symptoms (RSPS) part I: theoretical principles and subscale 1: perception symptoms (illusions and hallucinations).

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Schizophrenia Research

• Publication date

  1999-08-17

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/S0920-9964(99)00012-2PMID 10463458
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Striatal dopamine in motor activation and reward-mediated learning: steps towards a unifying model

  2005cited by this paper
• The time course of neuroleptic therapy for psychosis: role of learning processes and implications for concepts of psychotic illness

  2004cited by this paper
• Neuropsychological correlates of negative, disorganized and psychotic symptoms in schizophrenia.

  1998cited by this paper
• Symmetrical effects of amphetamine and alpha-flupenthixol on conditioned punishment and conditioned reinforcement: contrasts with midazolam

  1997cited by this paper
• The auditory hallucination: a phenomenological survey

  1996cited by this paper
• Dopamine reverses the depression of rat corticostriatal synapses which normally follows high-frequency stimulation of cortex in vitro.

  1996cited by this paper
• Somatic Delusions in Schizophrenia and the Affective Psychoses

  1995cited by this paper
• Negative, psychoticism, and disorganized dimensions in patients with familial schizophrenia or bipolar disorder: continuity and discontinuity between the major psychoses.

  1995cited by this paper
• Excitatory synaptic transmission in neostriatal neurons: regulation by cyclic AMP-dependent mechanisms

  1995cited by this paper
• A comparative study of thought disorder in acute and chronic schizophrenia.

  1995cited by this paper
• Positive or negative symptoms — which are more appropriate as diagnostic criteria for schizophrenia?

  1995cited by this paper
• In vivo D2 dopamine receptor density in psychotic and nonpsychotic patients with bipolar disorder.

  1995cited by this paper
• The organization of the basal ganglia-thalamocortical circuits: open interconnected rather than closed segregated.

  1994cited by this paper
• Spatial patterns in the background EEG underlying mental disease in man.

  1994cited by this paper
• Movement Disorders in Neurology and Neuropsychiatry

  1994cited by this paper
• Elevated dopa decarboxylase activity in living brain of patients with psychosis.

  1994cited by this paper
• Kaplan and Sadock's Synopsis of Psychiatry: Behavioral Sciences Clinical Psychiatry

  1994cited by this paper
• Striatal dopamine in reward and attention: a system for understanding the symptomatology of acute schizophrenia and mania.

  1993cited by this paper
• Dopamine D4 receptors elevated in schizophrenia

  1993cited by this paper
• Factor analysis of schizophrenic symptoms and comparison of different rating scales.

  1993cited by this paper
• Intellectual deficits in first-episode schizophrenia: evidence for progressive deterioration.

  1992cited by this paper
• Haloperidol plasma levels and clinical response: a therapeutic window relationship.

  1992cited by this paper
• D-1 receptor involvement in reward-related learning

  1992cited by this paper
• Tardive Dyskinesia and Type II Schizophrenia

  1992cited by this paper
• On the interpretation of asymmetries of posture and locomotion produced with dopamine agonists in animals with unilateral depletion of striatal dopamine.

  1991cited by this paper
• Posttraumatic Stress Disorder Following Recent‐Onset Psychosis An Unrecognized Postpsychotic Syndrome

  1991cited by this paper
• Cognitive dysfunction in schizophrenia followed up over 5 years, and its longitudinal relationship to the emergence of tardive dyskinesia

  1990cited by this paper
• Dopamine D-1 and D-2 receptors in relation to reward and performance: a case for the D-1 receptor as a primary site of therapeutic action of neuroleptic drugs.

  1990cited by this paper
• Differential Performance of Acute and Chronic Schizophrenics in a Latent Inhibition Task

  1988cited by this paper
• Reliability and validity of the positive and negative syndrome scale for schizophrenics.

  1988cited by this paper
• Information processing by the brain : views and hypotheses from a physiological-cognitive perspective

  1988cited by this paper
• The organization of behavior

  1988cited by this paper
• Biological studies in schizophrenia.

  1987cited by this paper
• Variant sexuality : research and theory

  1987cited by this paper
• The positive and negative syndrome scale (PANSS) for schizophrenia.

  1987cited by this paper
• Cerebral aspects of sexual deviation.

  1987cited by this paper
• Neuroleptic Blood Levels and Clinical Response

  1986cited by this paper
• Parallel organization of functionally segregated circuits linking basal ganglia and cortex.

  1986cited by this paper
• Evaluating bizarre-idiosyncratic thinking: a comprehensive index of positive thought disorder.

  1986cited by this paper
• Thought, language, and communication in schizophrenia: diagnosis and prognosis.

  1986cited by this paper
• The prognostic significance of obsessive-compulsive symptoms in schizophrenia.

  1986cited by this paper
• Lateralization of visual hallucinations in chronic schizophrenia.

  1985cited by this paper
• Positive and negative schizophrenic symptoms, attention, and information processing.

  1985cited by this paper
• Assessing Schizophrenic Thinking

  1984cited by this paper
• Major psychosis and dopamine: controversial features and some suggestions

  1984cited by this paper
• The role of dopamine in locomotor activity and learning.

  1983cited by this paper
• Meaning and Purpose in the Intact Brain

  1982cited by this paper
• Evidence of Brain Dopamine Deficiency in Schizophrenia

  1979cited by this paper
• Thought, language, and communication disorders. I. Clinical assessment, definition of terms, and evaluation of their reliability.

  1979cited by this paper
• Schizophrenia as dopamine-deficiency disease.

  1978cited by this paper
• The effect of anti-psychotic medication and diagnostic criteria on distractibility in schizophrenia.

  1978cited by this paper
• Auditory attention in process and reactive schizophrenia.

  1976cited by this paper
• A comparative study of haloperidol and chlorpromazine in terms of clinical effects and therapeutic reversal with benztropine in schizophrenia. Theoretical implications for potency differences among neuroleptics

  1975cited by this paper
• Retreat from Sanity: The Structure of Emerging Psychosis

  1974cited by this paper
• Psychosis and Temporal Lobe Epilepsy; A Controlled Investigation

  1969cited by this paper
• The Brief Psychiatric Rating Scale

  1962cited by this paper

• Different measures for auditory hallucinations in populations with psychosis. The Validation of the Spanish versions of the Auditory Vocal Hallucination Rating Scale (AVHRS) and the Positive and Useful Voices Inquiry (PUVI).

  2022cites this paper
• Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications

  2020cites this paper
• Different measures for auditory hallucinations in populations with psychosis. The Validation of the Spanish versions of the Auditory Vocal Hallucination Rating Scale (AVHRS) and the Positive and Useful Voices Inquiry (PUVI).

  2020cites this paper
• Hippocampal Hyperactivity as a Druggable Circuit-Level Origin of Aberrant Salience in Schizophrenia

  2020cites this paper
• Visual hallucinations associated with multimodal hallucinations, suicide attempts and morbidity of illness in psychotic disorders.

  2019cites this paper
• Ketamine and pharmacological imaging: use of functional magnetic resonance imaging to evaluate mechanisms of action

  2017cites this paper
• Measures of visual hallucinations: Review and recommendations.

  2017cites this paper
• Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy

  2017cites this paper
• A review of abnormalities in the perception of visual illusions in schizophrenia

  2016cites this paper
• Confidence and psychosis: a neuro-computational account of contingency learning disruption by NMDA blockade

  2015cites this paper
• Selective Augmentation of Striatal Functional Connectivity Following NMDA Receptor Antagonism: Implications for Psychosis

  2015cites this paper
• Şizofreni ve Mitokondri Disfonksiyonu Schizophrenia and Mitochondria Dysfunction

  2014cites this paper
• Selective augmentation of striatal functional connectivity following NMDA receptor antagonism: implications for psychosis

  2014cites this paper
• Human pharmacology of current and new treatments for schizophrenia

  2012cites this paper
• Cognition-Emotion Dysinteraction in Schizophrenia

  2012cites this paper
• Exploring the Impact of Ketamine on the Experience of Illusory Body Ownership

  2011cites this paper
• How antipsychotics work—From receptors to reality

  2011cites this paper
• All Roads to Schizophrenia Lead to Dopamine Supersensitivity and Elevated Dopamine D2High Receptors

  2011cites this paper
• Delusional procreation syndrome: A psychopathology in procreation of human beings.

  2010cites this paper
• The emerging biology of delusions

  2010cites this paper
• Mechanisms of Action of Antipsychotic Drugs of Different Classes, Refractoriness to Therapeutic Effects of Classical Neuroleptics, and Individual Variation in Sensitivity to their Actions: PART I

  2009cites this paper
• Neuroanatomical Pattern of Mitochondrial Complex I Pathology Varies between Schizophrenia, Bipolar Disorder and Major Depression

  2008cites this paper
• The GRID-HAMD: standardization of the Hamilton Depression Rating Scale

  2008cites this paper
• Cerebral glucose utilization and platelet mitochondrial complex I activity in schizophrenia: A FDG-PET study.

  2007cites this paper
• Cross-ethnic evaluation of psychotic symptom content in hospitalized middle-aged and older adults.

  2006cites this paper
• From dopamine to salience to psychosis--linking biology, pharmacology and phenomenology of psychosis.

  2005cites this paper
• How antipsychotics become anti-"psychotic"--from dopamine to salience to psychosis.

  2004cites this paper
• Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia.

  2003cites this paper
• [Evaluation of auditory hallucinations: the PSYRATS scale].

  2003cites this paper
• Assessing and Managing Compulsive Scratching in Schizophrenia with Chronic Renal Failure

  2002cites this paper
• Using the Rating Scale for Psychotic Symptoms to Characterize Delusions Expressed in a Schizophrenia Patient with “Internet Psychosis”

  2002cites this paper